Thursday, December 25, 2025 | 04:35 AM ISTहिंदी में पढें
SMS Pharmaceuticals Ltd News
SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets
At 10:40 AM, SMS Pharmaceuticals share price was trading 6.77 per cent higher at ₹292.55 per share. In comparison, BSE Sensex was trading 0.73 per cent higher at 85,204.25 levels.
 "SMS Pharma up 8% as arm gets USFDA nod for reformulated Ranitidine tablets")
Updated On : 26 Nov 2025 | 10:53 AM IST
SMS Pharmaceuticals shares zoom 10% on clean USFDA inspection report
SMS Pharmaceuticals shares rose 10 per cent after it received an Establishment Inspection Report with a No Action Indicated from the USFDA
 "SMS Pharmaceuticals shares zoom 10% on clean USFDA inspection report")
Updated On : 28 Aug 2025 | 10:46 AM IST
